Intro

Baxten Healthcare Pvt. Ltd., based in Mumbai, is a specialty pharmaceutical company that manufactures and distributes a diverse portfolio of healthcare products. These include intravenous infusions, ophthalmic solutions, sterilized water for injections, nebules, tablets, capsules, ointments, and creams.

Founded in 2001, our mission is to provide high-quality large and small volume parenterals at the most economical prices. We recognized the need for a leading pharmaceutical organization dedicated to producing assured quality products in this field.

Baxten boasts the largest production capacity for intravenous infusions in India. With the acquisition of Baxter International's FFS Division, our presence in both domestic and global markets has strengthened significantly.

To serve our domestic and international clients, we have strategically located manufacturing plants in Roorkee (North), Waluj (West), and Alathur (South).

Each year, our team connects with approximately 12,000 hospitals and nursing homes. We are expanding our capacities at all three locations to enhance our footprint in the Indian market and increase exports.

Our company has achieved significant quality certifications, including WHO-GMP, ISO 9001:2015, and PIC/S, marking our adherence to international standards. We have obtained certifications for various countries such as Ukraine, Kenya, the Philippines, Ivory Coast, Nepal, Nigeria, Uganda, and Kazakhstan, with more in progress.

year 2001

Inception of Baxten Healthcare i.e started marketing with pharmaceutical products
year 2003

Awarded One Star Export House status by the Government of India
year 2007

Started commercial production of Intravenous Infusions at Roorkee
year 2008

Received WHO – GMP certification and started exports to over 15 markets worldwide
year 2010

Awarded the Top Exporter Award for Medium Scale Enterprises by Chemexcil. Acquired the second unit in Roorkee for manufacturing oral dosage formulations
year 2014

Baxter USA, Global Audit Approval, and Approval from PICs
year 2016

OrbiMed investment into the Company. Agreement to acquire Baxter India’s IV business. Certification from ISO 9001:2015
year 2019

Acquisition of Teva’s IV Infusion Unit in Hungary